BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34919754)

  • 1. Low Levels of Hepatocyte-Specific Methylation in Cell-Free DNA Are a Strong Negative Predictor for Acute T Cell-Mediated Rejection Requiring Treatment Following Liver Transplantation.
    Cox DRA; Low N; Goh SK; Lee E; Vago A; Jackett L; Lokan J; Braat S; Jones R; Testro A; Dobrovic A; Muralidharan V
    Liver Transpl; 2022 Jun; 28(6):1024-1038. PubMed ID: 34919754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study.
    Cox DRA; McClure T; Zhang F; Wong BKL; Testro A; Goh SK; Muralidharan V; Dobrovic A
    Epigenomes; 2023 Jun; 7(2):. PubMed ID: 37367181
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation.
    Baumann AK; Beck J; Kirchner T; Hartleben B; Schütz E; Oellerich M; Wedemeyer H; Jaeckel E; Taubert R
    Liver Transpl; 2022 Dec; 28(12):1911-1919. PubMed ID: 35429207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants.
    Puliyanda DP; Swinford R; Pizzo H; Garrison J; De Golovine AM; Jordan SC
    Pediatr Transplant; 2021 Mar; 25(2):e13850. PubMed ID: 33217125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
    Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
    PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients.
    Levitsky J; Kandpal M; Guo K; Kleiboeker S; Sinha R; Abecassis M
    Am J Transplant; 2022 Feb; 22(2):532-540. PubMed ID: 34510731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant Recipients.
    Park S; Guo K; Heilman RL; Poggio ED; Taber DJ; Marsh CL; Kurian SM; Kleiboeker S; Weems J; Holman J; Zhao L; Sinha R; Brietigam S; Rebello C; Abecassis MM; Friedewald JJ
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1539-1551. PubMed ID: 34620649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients.
    Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q
    Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: A prospective multicenter study.
    Khush KK; Patel J; Pinney S; Kao A; Alharethi R; DePasquale E; Ewald G; Berman P; Kanwar M; Hiller D; Yee JP; Woodward RN; Hall S; Kobashigawa J
    Am J Transplant; 2019 Oct; 19(10):2889-2899. PubMed ID: 30835940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-derived Cell-free DNA as a Noninvasive Biomarker of Cardiac Allograft Rejection: A Cohort Study on Clinical Validity and Confounding Factors.
    Knüttgen F; Beck J; Dittrich M; Oellerich M; Zittermann A; Schulz U; Fuchs U; Knabbe C; Schütz E; Gummert J; Birschmann I
    Transplantation; 2022 Mar; 106(3):615-622. PubMed ID: 33653997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal Transplantation.
    Oellerich M; Budde K; Osmanodja B; Bornemann-Kolatzki K; Beck J; Schütz E; Walson PD
    Ther Drug Monit; 2023 Feb; 45(1):20-25. PubMed ID: 36127770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation.
    Fernández-Galán E; Badenas C; Fondevila C; Jiménez W; Navasa M; Puig-Butillé JA; Brunet M
    Liver Transpl; 2022 Feb; 28(2):257-268. PubMed ID: 34407295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel donor-derived cell-free DNA assay for the detection of acute rejection in heart transplantation.
    Kim PJ; Olymbios M; Siu A; Wever Pinzon O; Adler E; Liang N; Swenerton R; Sternberg J; Kaur N; Ahmed E; Chen YA; Fehringer G; Demko ZP; Billings PR; Stehlik J
    J Heart Lung Transplant; 2022 Jul; 41(7):919-927. PubMed ID: 35577713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived Cell-free DNA Shows High Sensitivity for the Diagnosis of Pancreas Graft Rejection in Simultaneous Pancreas-kidney Transplantation.
    Ventura-Aguiar P; Ramirez-Bajo MJ; Rovira J; Bañón-Maneus E; Hierro N; Lazo M; Cuatrecasas M; Garcia-Criado MA; Liang N; Swenerton RK; Cofan F; Cucchiari D; Esforzado N; Montagud-Marrahi E; Oppenheimer F; Piñeiro G; Revuelta I; Torregrosa V; Ahmed E; Soboleva K; Kaur N; Zimmermann BG; Al Haj Baddar N; Demko ZP; Escrig C; Tabriziani H; Gauthier P; Billings PR; Amor AJ; Ferrer J; Campistol JM; Diekmann F
    Transplantation; 2022 Aug; 106(8):1690-1697. PubMed ID: 35289777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
    Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
    J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between donor fraction cell-free DNA and clinical rejection in heart transplantation.
    Deshpande SR; Zangwill SD; Kindel SJ; Schroder JN; Bichell DP; Wigger MA; Richmond ME; Knecht KR; Pahl E; Gaglianello NA; Mahle WT; Stamm KD; Simpson PM; Dasgupta M; Zhang L; North PE; Tomita-Mitchell A; Mitchell ME
    Pediatr Transplant; 2022 Jun; 26(4):e14264. PubMed ID: 35258162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
    Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
    Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation.
    Richmond ME; Zangwill SD; Kindel SJ; Deshpande SR; Schroder JN; Bichell DP; Knecht KR; Mahle WT; Wigger MA; Gaglianello NA; Pahl E; Simpson PM; Dasgupta M; North PE; Hidestrand M; Tomita-Mitchell A; Mitchell ME
    J Heart Lung Transplant; 2020 May; 39(5):454-463. PubMed ID: 31983667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.